99 related articles for article (PubMed ID: 24900618)
1. Influenza RNA-Dependent RNA Polymerase (RdRp) Inhibitors: Potential New Therapy for Influenza Treatment.
Abdel-Magid AF
ACS Med Chem Lett; 2013 Dec; 4(12):1133-4. PubMed ID: 24900618
[No Abstract] [Full Text] [Related]
2. Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions.
Massari S; Desantis J; Nizi MG; Cecchetti V; Tabarrini O
ACS Infect Dis; 2021 Jun; 7(6):1332-1350. PubMed ID: 33044059
[TBL] [Abstract][Full Text] [Related]
3. Assays to Measure the Activity of Influenza Virus Polymerase.
Te Velthuis AJW; Long JS; Barclay WS
Methods Mol Biol; 2018; 1836():343-374. PubMed ID: 30151582
[TBL] [Abstract][Full Text] [Related]
4. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.
Su WC; Hsu SF; Lee YY; Jeng KS; Lai MM
J Virol; 2015 Nov; 89(22):11245-55. PubMed ID: 26311876
[TBL] [Abstract][Full Text] [Related]
5. A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus.
Zhao X; Wang Y; Cui Q; Li P; Wang L; Chen Z; Rong L; Du R
Viruses; 2019 Sep; 11(9):. PubMed ID: 31491939
[TBL] [Abstract][Full Text] [Related]
6. Interplay between Influenza Virus and the Host RNA Polymerase II Transcriptional Machinery.
Walker AP; Fodor E
Trends Microbiol; 2019 May; 27(5):398-407. PubMed ID: 30642766
[TBL] [Abstract][Full Text] [Related]
7. Influenza Virus Infection Induces Host Pyruvate Kinase M Which Interacts with Viral RNA-Dependent RNA Polymerase.
Miyake Y; Ishii K; Honda A
Front Microbiol; 2017; 8():162. PubMed ID: 28232820
[TBL] [Abstract][Full Text] [Related]
8. Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus Agents.
Giacchello I; Musumeci F; D'Agostino I; Greco C; Grossi G; Schenone S
Curr Med Chem; 2021; 28(6):1068-1090. PubMed ID: 31942843
[TBL] [Abstract][Full Text] [Related]
9. High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity.
Su CY; Cheng TJ; Lin MI; Wang SY; Huang WI; Lin-Chu SY; Chen YH; Wu CY; Lai MM; Cheng WC; Wu YT; Tsai MD; Cheng YS; Wong CH
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19151-6. PubMed ID: 20974907
[TBL] [Abstract][Full Text] [Related]
10. Tyr82 Amino Acid Mutation in PB1 Polymerase Induces an Influenza Virus Mutator Phenotype.
Naito T; Shirai K; Mori K; Muratsu H; Ushirogawa H; Ohniwa RL; Hanada K; Saito M
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462570
[TBL] [Abstract][Full Text] [Related]
11. Structure resolution of the trimeric RNA-dependent RNA polymerase of influenza viruses: impact on our understanding of polymerase interactions with host and viral factors.
Biquand E; Demeret C
Virologie (Montrouge); 2016 Dec; 20(6):32-48. PubMed ID: 32187969
[TBL] [Abstract][Full Text] [Related]
12. Structure resolution of the trimeric RNA-dependent RNA polymerase of influenza viruses: impact on our understanding of polymerase interactions with host and viral factors.
Biquand É; Demeret C
Virologie (Montrouge); 2016 Dec; 20(6):302-320. PubMed ID: 32187967
[TBL] [Abstract][Full Text] [Related]
13. Regulation of influenza RNA polymerase activity and the switch between replication and transcription by the concentrations of the vRNA 5' end, the cap source, and the polymerase.
Olson AC; Rosenblum E; Kuchta RD
Biochemistry; 2010 Nov; 49(47):10208-15. PubMed ID: 21033726
[TBL] [Abstract][Full Text] [Related]
14. Naphthalene-sulfonate inhibitors of human norovirus RNA-dependent RNA-polymerase.
Tarantino D; Pezzullo M; Mastrangelo E; Croci R; Rohayem J; Robel I; Bolognesi M; Milani M
Antiviral Res; 2014 Feb; 102():23-8. PubMed ID: 24316032
[TBL] [Abstract][Full Text] [Related]
15. AZT acts as an anti-influenza nucleotide triphosphate targeting the catalytic site of A/PR/8/34/H1N1 RNA dependent RNA polymerase.
Pagadala NS
J Comput Aided Mol Des; 2019 Apr; 33(4):387-404. PubMed ID: 30739239
[TBL] [Abstract][Full Text] [Related]
16. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
Zhou Z; Liu T; Zhang J; Zhan P; Liu X
Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
[TBL] [Abstract][Full Text] [Related]
17. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and Replication.
Wang Z; Zhao F; Gao Q; Liu Z; Zhang Y; Li X; Li Y; Ma W; Deng T; Zhang Z; Cen S
PLoS One; 2015; 10(7):e0133558. PubMed ID: 26196128
[TBL] [Abstract][Full Text] [Related]
19. Progress of small molecular inhibitors in the development of anti-influenza virus agents.
Wu X; Wu X; Sun Q; Zhang C; Yang S; Li L; Jia Z
Theranostics; 2017; 7(4):826-845. PubMed ID: 28382157
[TBL] [Abstract][Full Text] [Related]
20. Polycistronic Expression of the Influenza A Virus RNA-Dependent RNA Polymerase by Using the Thosea asigna Virus 2A-Like Self-Processing Sequence.
Momose F; Morikawa Y
Front Microbiol; 2016; 7():288. PubMed ID: 27014212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
